Tag Archives: medical technology

Pressemitteilungen

Embedded World: ARIES Embedded Will Present New System-on-Module with PolarFire FPGA

M100PF Board Enhances and Optimizes Microchip’s PolarFire FPGA for Industrial and Medical Technology

ARIES Embedded, specialist for embedded services and products, will display the new M100PF System-on-Module (SoM) based on Microchip’s PolarFire FPGA (Field Programmable Gate Array) family at Embedded World from February 26 to 28, 2019 in Nuremburg, Germany. At stand 441 in hall 3A, the embedded specialist will also introduce the complementary evaluation platform M100PFEVP, which delivers a fast and easy project start for customers. „Our new M100PF board provides the full flexibility of the popular FPGAs for demanding applications in industrial and medical technology,“ stated Andreas Widder, Managing Director of ARIES Embedded. „PolarFire captivates with up to 50 percent lower power consumption than competing FPGAs, at mid-range densities with exceptional safety and reliability.“ With the SoM, ARIES Embedded extends the FPGA functionality with RAM, Flash, Clocking and additional features.

M100PF Flexibly and Reliably Serves Industrial Applications

For industrial use, the system-on-module allows an expanded temperature range, from 0° to +70°C up to -40° to +85°C. On the ARIES SoM, the PolarFire FPGAs provide 100k, 192k, or 300k logic elements (LE) and feature 12.7G transceivers with up to 50 percent lower power consumption. The 256 Mbit configuration storage, the DDR3 RAM (512 Mbit, 1 or 2 Gbit), as well as 4 to 64 Gbit eMMC NAND Flash allow the development of complex high performance designs. Further features of the 72 by 40 mm small SoMs are: 8 SerDes with 250 Mbps to 12.5 Gbps, 2 PCI express Gen2 end points/root port slots, rich user I/O, and 2 Samtec QSH-090-01-F-D-A board-to-board connectors.

Easy Project Start with Evaluation Board M100PFEVP

ARIES Embedded provides the corresponding evaluation platform M100PFEVP for a smooth and fast project start. It enables customers to evaluate the PolarFire FPGA, realize prototypes and even use the FPGA in series production. The evaluation board contains 2 gigabit Ethernet, USB, and 4 DSub9 interfaces for CAN, RS232, and others, in addition to Pmod and HSMC extension connectors and a microSD card slot. The M100PFEVP starter kit includes the M100PVEVP baseboard, M100PF-1DB storage extensions, a 7-inch touchscreen, and power supply.

About ARIES Embedded
ARIES Embedded provides hardware and software development and standard products for industrial and agricultural sectors. The 2001 founded embedded specialist headquartered in Fuerstenfeldbruck, Germany, focuses on FPGA technology and open source software. The portfolio comprises of modular systems for flexible and fast use in functional prototypes, pilot series and mass production. On customer request, ARIES Embedded individually customizes standard products in accordance with project requirements.

Company-Contact
ARIES Embedded GmbH
Andreas Widder
Schöngeisinger Straße 84
82256 Fürstenfeldbruck
Phone: +49 8141 36 367 0
E-Mail: ma@ahlendorf-communication.com
Url: http://www.aries-embedded.com

Press
ahlendorf communication
Mandy Ahlendorf
Hermann-Roth-Straße 1
82065 Baierbrunn
Phone: +49 89 41109402
E-Mail: ma@ahlendorf-communication.com
Url: http://www.ahlendorf-communication.com

Die Bildrechte liegen bei dem Verfasser der Mitteilung.

Pressemitteilungen

Embedded World: ARIES Embedded präsentiert neues System-on-Module mit PolarFire FPGA

M100PF-Board erweitert und optimiert Microchips PolarFire FPGA für Industrie und Medizintechnik

ARIES Embedded, Spezialist für Embedded-Services und -Produkte, präsentiert auf der Embedded World vom 26. bis 28. Februar 2019 in Nürnberg das neue System-on-Module (SoM) M100PF auf Basis der PolarFire FPGA-Familie (Field Programmable Gate Array) von Microchip. Am Stand 441 in Halle 3A stellt der Embedded-Spezialist zudem die ergänzende Evaluierungsplattform M100PFEVP vor, die Kunden einen schnellen und einfachen Projektstart ermöglicht. „Unser neues M100PF-Board bietet die volle Flexibilität der beliebten FPGAs für anspruchsvolle Anwendungen in Industrie und Medizintechnik“, erläutert Andreas Widder, Geschäftsführer von ARIES Embedded. „Der PolarFire besticht durch bis zu 50 Prozent niedrigere Leistungsaufnahme als andere FPGAs, und das bei mittlerer Dichte und außerordentlicher Sicherheit und Zuverlässigkeit.“ Mit dem SoM erweitert ARIES Embedded die FPGA-Funktionalität um RAM, Flash, Clocking und weitere Features.

M100PF bedient Industrieanwendungen flexibel und zuverlässig

Für den industriellen Einsatz erlaubt das System-on-Module einen von 0° bis +70°C auf -40° bis +85°C erweiterten Temperaturbereich. Die PolarFire-FPGAs auf dem ARIES SoM bieten 100k, 192k oder 300k Logikelemente (LE) und einen 12,7G-Transceiver bei bis 50 Prozent geringerem Stromverbrauch. Der Konfigurationsspeicher mit 256 MBit und das DDR3 RAM mit 512 MBit, 1 oder 2 GBit sowie 4 bis 64 GBit eMMC NAND Flash ermöglichen die Entwicklung komplexer Hochleistungsdesigns. Weitere Features des nur 72 auf 40 mm großen SoMs sind: 8 SerDes mit 250 MBit/s bis12,5 GBit/s, 2 PCI-Express Gen2 Endpunkt/Rootport-Steckplätze, Rich-User In-/Output und 2 Samtec QSH-090-01-F-D-A Board-to-Board-Steckverbinder.

Einfacher Projektstart mit Evaluierungsboard M100PFEVP

Für einen reibungslosen und schnellen Projektstart stellt ARIES Embedded die entsprechende Evaluierungsplattform M100PFEVP bereit. Damit können die Kunden das PolarFire FPGA evaluieren, Prototypen realisieren und den FPGA sogar in Serie verwenden. Das Evaluierungsboard enthält 2 Gigabit-Ethernet-, USB- sowie 4 DSub9-Schnittstellen für CAN, RS232, etc., außerdem Pmod-und HSMC-Erweiterungsstecker und einen microSD-Kartensteckplatz. Das Starterpaket M100PFEVP-Kit umfasst das M100PFEVP-Baseboard, M100PF-1DB Speichererweiterungen, einen 7-Zoll-Touchscreen und ein Netzteil.

Über ARIES Embedded
ARIES Embedded bietet kundenspezifische Hardware- und Software-Entwicklung und Standardprodukte für Industrie und Landwirtschaft. Der Schwerpunkt des 2001 gegründeten Embedded-Spezialisten mit Sitz in Fürstenfeldbruck, Deutschland, liegt auf der FPGA-Technologie und Open-Source-Software. Das Angebot umfasst modulare Systeme für den flexiblen und schnellen Einsatz in funktionalen Prototypen, Pilotserien und der Serienproduktion. Im Kundenauftrag passt ARIES Embedded Standardprojekte individuell an Projektanforderungen an.

Firmenkontakt
ARIES Embedded GmbH
Andreas Widder
Schöngeisinger Straße 84
82256 Fürstenfeldbruck
+49 8141 36 367 0
ma@ahlendorf-communication.com
http://www.aries-embedded.com

Pressekontakt
ahlendorf communication
Mandy Ahlendorf
Hermann-Roth-Straße 1
82065 Baierbrunn
+49 89 41109402
ma@ahlendorf-communication.com
http://www.ahlendorf-communication.com

Die Bildrechte liegen bei dem Verfasser der Mitteilung.

Pressemitteilungen

TAITRA Presents Top Products at MEDICA 2018

TAITRA Presents Top Products at MEDICA 2018

The Taiwan External Trade Development Council (TAITRA) promotes the sale of Taiwanese products at home and abroad. At today’s MEDICA press conference, TAITRA focused on particularly innovative products from the fields of medical technology and e-health.

Düsseldorf, 13 November 2018
Five Taiwanese exhibitors took the opportunity to present their latest product innovations to international trade journalists. At the invitation of TAITRA, representatives from HTC, Taiwan Main Orthopedics, AmCad BioMed, BAUI Biotech and Rehabotics Medical Technology stood before an engaged audience and presented insights into the ambitious research and development work in Taiwan as well as their latest product innovations.

For example, the HTC Group relies heavily on virtual reality and impresses in two respects with the VR glasses VIVE. First, VIVE provides access to the first anatomical 3D atlas. On the other hand, the glasses have already achieved initial successes in the therapy of the fear of heights. Absolutely innovative is the fact that the therapy is accompanied by a virtual trainer instead of a human therapist.

The Virtual Dissection Table and the surgical glasses from Taiwan Main Orthopedics are also highly technical. The treatment table, which displays fully anatomical structures and, is suitable both for teaching purposes and for planning surgical interventions. The intelligent surgical spectacles complement the range and enable doctors to partially look into the patient’s body during a minimally invasive procedure and to display a 3D model of nerves and vessels.

AmCad BioMed Corporation is countering obstructive sleep apnea syndrome with a promising new diagnostic device. The AmCAD-UO consists of a positioning system and computer-aided recognition software. After only ten minutes, the AmCAD-UO provides accurate results and thus ensures efficiency and flexibility in treatment.

After two years of research and development, BAUI Biotech launches the NOVA Minimally Invasive System, which can be used to optimize surgical procedures on the spine. Both the patient and the surgeon benefit from the versatile small screw. The NOVA system effectively stabilizes the spinal column using polyaxial screws with long, fragile blades.

Rehabotics Medical Technology Corporation presents an innovative robotics product. The Mirror Hand was developed to support and accelerate the rehabilitation of the hands, for example after strokes, and to provide patients with practical help in coping with their everyday lives. Weighing only 750 grams, it is by far one of the lightest robotic rehabilitation devices for the hand.

Taiwan relies on technological progress
For many years, Taiwan has enjoyed an excellent reputation as a location for the manufacture of high-quality consumer electronics and medical technology equipment, which the small country has now been able to develop into a significant competitive advantage. TAITRA is committed to those companies that are entering the market with particularly innovative ideas and acts as a partner, mediator and consultant when it comes to initiating and concluding transactions between Taiwanese companies and customers at home and abroad. At the TAITRA joint exhibition stand at the current MEDICA, 15 companies present their new products, which have received the „Taiwan Excellence Award“.

About TAITRA:
TAITRA was founded in 1970 as a non-profit trade promotion organization. Supported by the Taiwanese government, TAITRA opens up new national and international sales markets for member companies from various sectors. TAITRA has created the „Taiwan Excellence“ label, which is awarded every year to particularly innovative products or companies. TAITRA is headquartered in Taiwan’s capital Taipei. The organization has a total of 61 branches worldwide. In Germany, TAITRA has two offices in Düsseldorf and Munich.

Founded in 1970 to help promote foreign trade, the Taiwan External Trade Development Council (TAITRA) is the foremost non-profit trade promotion organization in Taiwan. Jointly sponsored by the government, industry associations, and several commercial organizations, TAITRA assists Taiwan businesses and manufacturers with reinforcing their international competitiveness and in coping with the challenges they face in foreign markets.

TAITRA boasts a well-coordinated trade promotion and information network of over 1,300 trained specialists stationed throughout its Taipei headquarters, four local branch offices in Hsinchu, Taichung, Tainan and Kaohsiung, and 60 overseas branch offices worldwide. Together with its sister organizations, Taiwan Trade Center (TTC) and Taipei World Trade Center (TWTC), TAITRA has created a wealth of trade opportunities through effective promotion strategies.

Company-Contact
Taiwan External Trade Development Council
Frances Lin
Immermannstr. 33
40210 Dusseldorf
Phone: +49 (0)228 / 919 37 -66
E-Mail: taiwanexcellence@agentur-drilling.de
Url: https://www.taiwanexcellence2018.de/pk/

Press
DRILLING GmbH
Ben Giese
CelsiusStr. 43
53125 Bonn
Phone: +49 (0)228 / 919 37 -66
E-Mail: taiwanexcellence@agentur-drilling.de
Url: https://www.taiwanexcellence2018.de/pc/

Pressemitteilungen

biolitec® Medica 2017

FiLaC® confirms success with long-term study – New therapy method for endometriosis – Mobile LEONARDO® Mini laser can also be used for varicose veins

biolitec® Medica 2017

LEONARDO® laser family by biolitec® (Source: @ biolitec®)

Jena, November 13, 2017 – The success of FiLaC® therapy for the particularly painless and sphincter-friendly removal of anal fistulas from biolitec®, the technology leader in minimally invasive laser therapy, has been confirmed by a recently published long-term study. Very good results in first-line therapy (64.1%) and even better second-line treatment cure rates (85.5%). The study was carried out between October 2009 and July 2014 at the rectum and pelvic floor centre in Cologne (EBZ) by Dr. A. Wilhelm and other researchers on 117 patients.

With ELLA, the new treatment method for endometriosis, biolitec® is expanding its range of therapies in the field of gynaecology. The low-maintenance LEONARDO® DUAL 45 diode laser with its thin, high-quality flexible glass fibers and narrow laparoscopic tubes enables precise control of the laser beam. Initial results of a study confirm the rapid recovery of the AMH value and the significant maintenance of the ovarian reserve.

The biolitec® team will be presenting the whole range of the proven LEONARDO® laser family at booth H46 in hall 10.
The LEONARDO® laser family includes the LEONARDO® Dual series lasers in the 45 Watt, 100 Watt and 200 Watt power ranges, which are all characterized by the continuous use of the two wavelengths 980nm and 1470nm during the treatment. These lasers are the most versatile medical lasers available on the market today. They are suitable for phlebology and proctology as well as minimally invasive procedures in urology, gynaecology, orthopaedics, thoracic surgery and pneumology.

The innovative LEONARDO® Mini has also been part of the family for a year. Weighing only 900 grams this device is available in a version with a wavelength of 1470nm and as LEONARDO® Mini Dual with the two wavelengths 980nm and 1470nm. The small laser can also be used mobile in the established treatment methods of biolitec® for venous diseases, haemorrhoids, fistulas, a broad range of ENT disorders and gynaecological diseases. In addition, the new LEONARDO® Mini can carry out the proven ELVeS® Radial® 2ring laser therapy for the treatment of varicose veins. Sports injuries, inflammations and overloads can be treated quickly, precisely and non-invasively with the 15 Watt LEONARDO® Mini Athletic, which is available in the combinable wavelengths 810nm and 980nm.

The proven, unique XCAVATOR® laser fiber for the treatment of benign prostatic hyperplasia (BPH) has been significantly improved by biolitec®. Thanks to the optimized absorption capacity in water and hemoglobin, the new XCAVATOR® fiber enables the surgeon to work even faster and more precisely, so that the minimally invasive LIFE procedure of biolitec® can reduce side effects and pain even better than before.

biolitec® also opened its own branch office in Switzerland half a year ago, in order to be able to take into account the importance and high standards of the Swiss medical technology market. At www.biolitec.com, interested parties can find out more about the innovative laser therapies of biolitec®. From November 13 to 16 biolitec® will be represented at the Medica in Dusseldorf at booth H46 in hall 10.

About biolitec
biolitec® is one of the world“s leading medical technology companies in the field of laser applications and the only provider which possesses all the relevant core competences in the field of photodynamic therapy (PDT) – photosensitizers, lasers and fibre optic cables. Besides laser-supported treatment of cancers with the drug Foscan®, biolitec® researches and markets above all minimally invasive, gentle laser procedures.
ELVeS® Radial® (Endo Laser Vein System) is the world“s most-used laser system to treat venous insufficiency. The LEONARDO® diode laser from biolitec® is the first universally applicable medical laser which has a combination of two wavelengths, 980nm and 1470nm, and which can be used across disciplines. The innovative contact fibre XCAVATOR® in conjunction with the LEONARDO® DUAL 200 Watt laser allows in urology a gentle treatment of e.g. benign prostate enlargement (BPH). The light-weight LEONARDO® Mini laser weighing only 900 g was developed especially for mobile application on site. Gentle laser applications in the fields of proctology, ENT, gynecology, thorax surgery and pneumology are also part of biolitec®“s field of business. More information available at www.biolitec.com

Contact
biolitec biomedical technology GmbH
Joern Gleisner
Otto-Schott-Str. 15
07745 Jena
Phone: +49 (0) 3641 / 51953-36
Fax: +49 (0) 6172 / 27159-69
E-Mail: joern.gleisner@biolitec.com
Url: http://www.biolitec.com

Pressemitteilungen

Biologisation of medical technology – partner companies wanted

ZIM supports new „BioHyMed“ network project for developing biohybrid products

Biologisation of medical technology - partner companies wanted

The BioHyMed kick-off meeting participants (Source: BioRegio STERN/Anne Faden)

(Stuttgart) – The Central Innovation Programme for SMEs (ZIM) of the German Federal Ministry for Economic Affairs and Energy (BMWi) is now supporting the new „BioHyMed“ project as a ZIM cooperation network. For at least a year, BioRegio STERN Management GmbH will now receive a total of 116,000 euros to establish a network for developing biohybrid products and processes. Together with universities, clinics and scientific institutions in the region and six SMEs as project partners, this will drive forward the biologisation of medical technology. More companies are welcome to join the network as project partners. They will receive targeted support to enable them to also submit promising applications for research and development to ZIM if required.

The participants in the new BioHyMed network are engaged in research and development in one of the most ground-breaking fields of the health care industry – the biologisation of medical technology. The combination of biological and technical products or processes – called biohybrids – will in future be commonplace in operating theatres. These include implants that either replace damaged cells, tissue or organs or stimulate the healing process – regeneration rather than replacement. The real challenges for medical technology are also the new procedures for integrating biological processes, mechanical instruments and high-tech electronics. Another aim of the BioHyMed project is to develop new methods and materials for coating and „activating“ surfaces using biological components. Coatings using tailored biomolecules or the body’s own cells promise better healing and fewer rejection reactions.

In-vitro diagnostics is another area covered by the project. This includes innovative analysis systems to identify hospital germs quickly and reliably on site, for example, but also companion diagnostics and biomarker identification procedures i.e. genetic investigations for planning customised therapy. For Project Manager Dr. Verena Grimm from BioRegio STERN Management GmbH, patient benefits are the project“s top priority. „Linking biotechnology and medical technology opens up entirely new diagnostic and therapeutic approaches.“

The Verein zur Förderung der Biotechnologie und Medizintechnik e.V. was the original initiator of the project, and the successful application to ZIM was then submitted by BioRegio STERN Management GmbH. The Verein is an associated partner and will provide an advisory council to undertake expert assessments of funding applications from new project partners. TETEC GmbH, the NMI Natural and Medical Sciences Institute, Medical Valley Hechingen Akademie e.V. and the urology clinic and Institute of Medical Microbiology and Hygiene at Eberhard Karls University Tübingen are also associated partners.

The BioHyMed project will initially receive a total of 116,000 euros over one year from ZIM and will launch on April 1 with these six SMEs from BioRegio STERN:
-HB Technologies GmbH, Tübingen
-BioTeSys GmbH, Esslingen
-CeGaT GmbH, Tübingen
-Computomics GmbH, Tübingen
-Mediagnost GmbH, Reutlingen
-PolyMedics Innovations GmbH, Denkendorf.
However, more SMEs are welcome. „We offer interested companies the uncomplicated opportunity to also become project partners,“ explains Dr. Grimm. „A consortium of several partners can even submit project applications to ZIM with a value of up to two million euros.“

About BioRegio STERN Management GmbH:
BioRegio STERN Management GmbH is a skill-sharing network, providing a help and ad-vice centre for founders of new businesses, entrepreneurs and researchers in the life sciences sector in the cities of Stuttgart, Tübingen, Esslingen and Reutlingen and the Stuttgart and Neckar-Alb regions. BioRegio STERN Management GmbH represents the interests of these market players in dealings with political circles, the media and associations and provides advice on grant applications and corporate financing. Key focal points include regenerative medicine, medical technology and the automation of biotechnology. Managing Director Dr. Klaus Eichenberg is a molecular and cell biologist and investment analyst.

Firmenkontakt
BioRegio STERN Management GmbH
Klaus Eichenberg
Friedrichstrasse 10
70174 Stuttgart
+49 (0)711-870354-0
info@bioregio-stern.de
http://www.bioregio-stern.de/en

Pressekontakt
Zeeb Kommunikation GmbH
Anja Pätzold
Hohenheimer Straße 58a
70174 Stuttgart
+49 (0)711-6070719
info@zeeb.info
http://www.zeeb.info

Pressemitteilungen

Understand industries, connect industries

HR news BioRegio STERN Management GmbH – Biotechnologist Dr. Verena Grimm is new project manager

Understand industries, connect industries

Dr. Verena Grimm, project manager BioRegio STERN Management GmbH (Source: private)

(Stuttgart) – Dr. Verena Grimm joined the BioRegio STERN Management GmbH team as a project manager in January 2017. The biotechnologist completed a tri-national degree course in Germany, Switzerland and France at the Ecole superieure de Biotechnologie de Strasbourg. After undertaking her dissertation at the University of Michigan in the United States, she received a doctorate from the Institute of Technical Biochemistry at the University of Stuttgart. She then worked for Greiner Bio-One GmbH for ten years as a product and marketing manager for multiplex analysis methods used in food safety, pharmaceutical product safety and human diagnostics. „This broad-ranging knowledge enables me to understand and reach various industries more easily,“ explains the 41-year-old. „As a project manager for BioRegio STERN Management GmbH, I will be able to put my expertise in developing, applying and marketing biotechnological methods to good use in improving links between local companies in the medical technology and biotechnology industry and help them develop opportunities for automated applications.“

About BioRegio STERN Management GmbH:
BioRegio STERN Management GmbH is a skill-sharing network, providing a help and ad-vice centre for founders of new businesses, entrepreneurs and researchers in the life sciences sector in the cities of Stuttgart, Tübingen, Esslingen and Reutlingen and the Stuttgart and Neckar-Alb regions. BioRegio STERN Management GmbH represents the interests of these market players in dealings with political circles, the media and associations and provides advice on grant applications and corporate financing. Key focal points include regenerative medicine, medical technology and the automation of biotechnology. Managing Director Dr. Klaus Eichenberg is a molecular and cell biologist and investment analyst.

Firmenkontakt
BioRegio STERN Management GmbH
Klaus Eichenberg
Friedrichstrasse 10
70174 Stuttgart
+49 (0)711-870354-0
info@bioregio-stern.de
http://www.bioregio-stern.de/en

Pressekontakt
Zeeb Kommunikation GmbH
Anja Pätzold
Hohenheimer Strasse 58a
70184 Stuttgart
+49 (0)711-6070719
info@zeeb.info
http://www.zeeb-kommunikation.de

Wissenschaft/Forschung

Medical Technology Report OnElMinda Ltd. – Product Pipeline Analysis, 2016

„The Report ElMinda Ltd. – Product Pipeline Analysis, 2016 Update provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz“

ElMinda Ltd. (ElMinda) is a medical technology company that offers brain disorder management solutions. The company provides tools and technologies in the areas of neuropsychological tests, functional magnetic resonance imaging, positron emission tomography, electroencephalography and magnetic encephalography. Its neuropsychological tests comprise questionnaires, pencil and paper test, computerized NP tests and continuous performance tests and behavioral or performance tests that provide an assessment of cognitive functioning. The company offers research and development programs in the areas of recovery management, pharmacologic treatment optimization, ADHD diagnosis and treatment optimization, pain management, early detection of neurodegenerative diseases, and mood disorders. It has its presence in Israel and the US. ElMinda is headquartered in Herzliya, Israel.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

View Report At http://www.marketresearchreports.biz/analysis/877740

Scope:

– The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

– The report analyzes all pipeline products in development for the company ElMinda Ltd.

– The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

– The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

– The report provides detailed description of products in development, technical specification and functions

– The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

– Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

– Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

– To formulate effective Research & Development strategies

– Develop market-entry and market expansion strategies

– Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

– Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc

– Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Download Sample copy of this Report at : http://www.marketresearchreports.biz/sample/sample/877740

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

ElMinda Ltd. Company Overview 5

ElMinda Ltd. Company Snapshot 5

ElMinda Ltd. Pipeline Products and Clinical Trials Overview 6

ElMinda Ltd. Pipeline Analysis Overview 7

Key Facts 7

ElMinda Ltd. – Major Products and Services 8

ElMinda Ltd. Pipeline Products by Development Stage 9

ElMinda Ltd. Pipeline Products Overview 11

BNA Platform – ADHD 11

BNA Platform – ADHD Product Overview 11

BNA Platform – Alzheimer’s Disease 12

BNA Platform – Alzheimer’s Disease Product Overview 12

BNA Platform – Migraine 13

BNA Platform – Migraine Product Overview 13

BNA Platform – Mood Disorder 14

BNA Platform – Mood Disorder Product Overview 14

BNA Platform – Pain 15

BNA Platform – Pain Product Overview 15

BNA Platform – Parkinson’s Disease 16

BNA Platform – Parkinson’s Disease Product Overview 16

ElMinda Ltd. – Key Competitors 17

ElMinda Ltd. – Key Employees 18

ElMinda Ltd. – Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

ElMinda Ltd., Recent Developments 20

Jun 03, 2016: Study Utilizing ElMindAs BNA Awarded the International Clinical Scholar Award at American College of Sports Medicine Annual Meeting 20

Mar 02, 2016: ElMindA to Present at the Eleventh World Congress on Brain Injury: BNA As a Physiological Marker for Sports-Related Concussion 20

Apr 12, 2015: ElMindA Announces approval of BNA Analysis System by the Israeli Ministry of Health 21

Aug 04, 2014: ElMindA Announces FDA Clearance of BNA Analysis System 21

Aug 04, 2014: ElMindA Announces FDA Clearance of BNA Analysis System 22

Appendix 23

Methodology 23

About GlobalData 23

Contact Us 23

Disclaimer 23

Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz

Wissenschaft/Forschung

„The Report ElMinda Ltd. – Product Pipeline Analysis, 2016 Update provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz“

ElMinda Ltd. (ElMinda) is a medical technology company that offers brain disorder management solutions. The company provides tools and technologies in the areas of neuropsychological tests, functional magnetic resonance imaging, positron emission tomography, electroencephalography and magnetic encephalography. Its neuropsychological tests comprise questionnaires, pencil and paper test, computerized NP tests and continuous performance tests and behavioral or performance tests that provide an assessment of cognitive functioning. The company offers research and development programs in the areas of recovery management, pharmacologic treatment optimization, ADHD diagnosis and treatment optimization, pain management, early detection of neurodegenerative diseases, and mood disorders. It has its presence in Israel and the US. ElMinda is headquartered in Herzliya, Israel.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

View Report At http://www.marketresearchreports.biz/analysis/877740

Scope:

– The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

– The report analyzes all pipeline products in development for the company ElMinda Ltd.

– The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

– The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

– The report provides detailed description of products in development, technical specification and functions

– The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

– Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

– Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

– To formulate effective Research & Development strategies

– Develop market-entry and market expansion strategies

– Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

– Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc

– Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Download Sample copy of this Report at : http://www.marketresearchreports.biz/sample/sample/877740

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

ElMinda Ltd. Company Overview 5

ElMinda Ltd. Company Snapshot 5

ElMinda Ltd. Pipeline Products and Clinical Trials Overview 6

ElMinda Ltd. Pipeline Analysis Overview 7

Key Facts 7

ElMinda Ltd. – Major Products and Services 8

ElMinda Ltd. Pipeline Products by Development Stage 9

ElMinda Ltd. Pipeline Products Overview 11

BNA Platform – ADHD 11

BNA Platform – ADHD Product Overview 11

BNA Platform – Alzheimer’s Disease 12

BNA Platform – Alzheimer’s Disease Product Overview 12

BNA Platform – Migraine 13

BNA Platform – Migraine Product Overview 13

BNA Platform – Mood Disorder 14

BNA Platform – Mood Disorder Product Overview 14

BNA Platform – Pain 15

BNA Platform – Pain Product Overview 15

BNA Platform – Parkinson’s Disease 16

BNA Platform – Parkinson’s Disease Product Overview 16

ElMinda Ltd. – Key Competitors 17

ElMinda Ltd. – Key Employees 18

ElMinda Ltd. – Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

ElMinda Ltd., Recent Developments 20

Jun 03, 2016: Study Utilizing ElMindAs BNA Awarded the International Clinical Scholar Award at American College of Sports Medicine Annual Meeting 20

Mar 02, 2016: ElMindA to Present at the Eleventh World Congress on Brain Injury: BNA As a Physiological Marker for Sports-Related Concussion 20

Apr 12, 2015: ElMindA Announces approval of BNA Analysis System by the Israeli Ministry of Health 21

Aug 04, 2014: ElMindA Announces FDA Clearance of BNA Analysis System 21

Aug 04, 2014: ElMindA Announces FDA Clearance of BNA Analysis System 22

Appendix 23

Methodology 23

About GlobalData 23

Contact Us 23

Disclaimer 23

Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz

Pressemitteilungen

VIO 3 electrosurgical device receives Red Dot Award 2016

The interface of the new electrosurgical device by Erbe Elektromedizin was distinguished in the category Interface Design with the Red Dot Design Award.

VIO 3 electrosurgical device receives Red Dot Award 2016

VIO 3 Electrosurgical Unit

The jury was won over by the unique user interface of the touch display. The central element – the so-called sphere – is surrounded by concentrically arranged instrument icons and activation icons which can be moved around via drag and drop. On the main screen, the sphere displays cutting and coagulation parameters large enough to be clearly visible from the sterile field.

If a user wishes to activate an instrument with the footswitch, for example, he or she simply moves the footswitch symbol on the touchscreen underneath the corresponding instrument symbol. The device switches over from handle to footswitch activation quickly and easily.

The display showing which instrument is currently activated is clearly visible from the operating table. An enlarged image of the corresponding instrument symbol appears which is graphically connected to the main sphere. The convenient, intuitive operation of the VIO 3 does not serve an end in itself but rather constitutes an essential safety factor; the more precisely and simply a device can be handled, the less likely it is that an error will be made during a surgical intervention. The user can concentrate completely on the patient. The VIO 3 boasts intuitive operation facilitated by a stepGUIDE function which gives recommendations for assignment of sockets and illuminates frames on sockets with active instruments – these being elements which enhance the operating safety of the VIO 3. The VIO 3 with its 6 sockets can be used in combination with the APC 3 plasma surgery device.
The Red Dot Award for Interface Design and almost all responses from user circles confirm that touchscreen operation via drag and drop is truly outstanding.

Find further Information about VIO 3 on vio.erbe-med.com

Erbe Elektromedizin GmbH
Setting standards since 1851

As a family-owned and operated business, Erbe develops, manufactures and markets surgical systems for professional
use in various medical disciplines all over the world.
Erbe technology leads the market in many countries and is therefore an inherent part of the working processes in the OR.
The products are thus helping to provide the best possible treatment for patients.

The portfolio comprises devices and instruments for electrosurgery, vessel sealing, argon plasma coagulation (APC),
cryosurgery and hydrosurgery. By combining these technologies, innovative applications become possible, particularly in
general surgery, gastroenterology, gynecology, pulmonology and urology.
Erbe employs more than 900 people worldwide, over 630 of them in Germany. Approx. 120 employees work in research
and development. The intensive collaboration with renowned users from medical schools and hospitals is the key to success
with which Erbe successfully furthers developments in medicine.

Firmenkontakt
Erbe Elektromedizin GmbH
Thomas Hämmerle
Waldhoernlestraße 17
72072 Tuebingen
+49 7071 / 755-138
thomas.haemmerle@erbe-med.com
http://vio.erbe-med.com

Pressekontakt
Erbe Elektromedizin GmbH
Thomas Haemmerle
Waldhoernlestraße 17
72072 Tuebingen
+49 7071 / 755-138
thomas.haemmerle@erbe-med.com
http://vio.erbe-med.com

Pressemitteilungen

ulrich medical facilitates its trainees entry into professional life

ulrich medical facilitates its trainees entry into professional life

(Mynewsdesk) Beginning one’s professional life is an exciting time. It’s even better when companies make it easier for trainees to familiarize themselves with everyday working life. ulrich medical, an innovative medical technology manufacturer from Ulm, has even developed a multistage plan of action to accomplish this.

Acceptances for the trainee position are announced no later than November but the training itself doesn’t begin until September of the following year. ulrich medical has made this rather long period of time a bit shorter this year for the first time with a “get-to-know-you tour”. All new trainees along with their parents were invited to this event at the end of March. There was an enormous response – all of the trainees came and brought at least one parent along. During the combined tour through management buildings and production, the young people got to know their trainers and gathered their initial impressions of their new workplace environment. Together as a group, all questions were then answered in detail and initial contacts between participants were made. The feedback was enthusiastic. “Ultimately, we parents also gain an impression of our children’s future jobs,” said one delighted mother. “It’s great that we trainees have already had a chance to get to know each other. That made us feel less nervous,” added one trainee.

The next step will take place at the end of August. Shortly before the start of the training, the trainees will once again meet to spend an evening together in an informal atmosphere. “During bowling, it’s easy to start conversations with people. The shared experience connects people and helps eliminate the tension that is otherwise present on the first day of work,” confirms Anke Walkerling, head of HR at ulrich medical.

To conclude the familiarization process, the new trainees are invited to a joint workshop after a few weeks. Team-building will be frequently emphasized during this workshop in order to allow the young people to continue growing together as a group.

Fascinated with medical technology

ulrich medical develops, produces and markets innovative medical technology. Physicians and users worldwide trust our more than 100 years of experience. As one of the few in the industry with development and production in Germany, the medical technology company from Ulm places great value on „Made in Germany“.

Diese Pressemitteilung wurde via Mynewsdesk versendet. Weitere Informationen finden Sie im ulrich medical .

Shortlink zu dieser Pressemitteilung:
http://shortpr.com/mmtmek

Permanentlink zu dieser Pressemitteilung:
http://www.themenportal.de/gesundheit/ulrich-medical-facilitates-its-trainees-entry-into-professional-life-47482

Fascinated with medical technology

ulrich medical develops, produces and markets innovative medical technology. Physicians and users worldwide trust our more than 100 years of experience. With our product divisions spinal systems, contrast media injectors, foot surgery and surgical instruments, we offer a broad portfolio of innovative products.

We are one of the few in the industry with development and production in Germany and we rely on the most modern manufacturing technology. Our products stand worldwide for the highest degree of quality „Made in Germany“.

The number of employees at the headquarters in Ulm has by now grown to include more than 290. As an owner-run company, we operate independently and are proud of our continuous, healthy growth.

Firmenkontakt
ulrich medical
Isabelle Korger
Buchbrunnenweg 12
89081 Ulm
+49 (0)731 9654-103
i.korger@ulrichmedical.com
http://www.themenportal.de/gesundheit/ulrich-medical-facilitates-its-trainees-entry-into-professional-life-47482

Pressekontakt
ulrich medical
Isabelle Korger
Buchbrunnenweg 12
89081 Ulm
+49 (0)731 9654-103
i.korger@ulrichmedical.com
http://shortpr.com/mmtmek